EBSA-2026-0232-0001, Pharmaceutical Care Management Association (PCMA)

Summary: The Pharmaceutical Care Management Association (PCMA) supports the creation of a new category of limited excepted fertility benefits but requests specific refinements to ensure administrative feasibility. They advocate for clarifying the voluntary nature of the benefits, allowing for cycle-based treatment limits, providing guidance on coordination with major medical coverage and state mandates, and delaying the applicability date to January 1, 2029.